tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Alumis price target raised to $33 from $22 at Morgan Stanley
PremiumThe FlyAlumis price target raised to $33 from $22 at Morgan Stanley
18d ago
Alumis price target raised to $32 from $18 at Guggenheim
Premium
The Fly
Alumis price target raised to $32 from $18 at Guggenheim
18d ago
Alumis announces $175M common stock offering
Premium
The Fly
Alumis announces $175M common stock offering
19d ago
Alumis price target raised to $39 from $17 at Wells Fargo
PremiumThe FlyAlumis price target raised to $39 from $17 at Wells Fargo
19d ago
Alumis jumps 106% to $17.11 after psoriasis trial hits endpoints
Premium
The Fly
Alumis jumps 106% to $17.11 after psoriasis trial hits endpoints
19d ago
Alumis Unveils Positive Phase 3 Data for Psoriasis Drug
Premium
Company Announcements
Alumis Unveils Positive Phase 3 Data for Psoriasis Drug
19d ago
Alumis price target raised to $20 from $14 at H.C. Wainwright
PremiumThe FlyAlumis price target raised to $20 from $14 at H.C. Wainwright
1M ago
Alumis Inc. Advances Pipeline Amid Financial Challenges
Premium
Company Announcements
Alumis Inc. Advances Pipeline Amid Financial Challenges
2M ago
Alumis reports Q3 revenue $2.07M, consensus $3.14M
Premium
The Fly
Alumis reports Q3 revenue $2.07M, consensus $3.14M
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100